ResearcherTohoku UniversityActive in the last 2 years

Hiroo Imai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1319-724X; OpenAlex author ID A5102924182. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 2 papers

Papers 2

Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: stu… Co-author DOI 10.1186/s12885-024-11973-9 ↗
Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case Report. Co-author DOI 10.3390/curroncol31030112 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chikashi Ishioka · 2 shared papers, 2024 · strength 0.40
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗
- Paper Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case Report. DOI 10.3390/curroncol31030112 ↗
Atsushi Satō · 1 shared paper, 2024 · strength 0.21
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗
Kenji Amagai · 1 shared paper, 2024 · strength 0.21
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗
Hiroyuki Shibata · 1 shared paper, 2024 · strength 0.21
- Paper Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patie… DOI 10.1186/s12885-024-11973-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.